|
|
|
Insider
Information: |
Love Ted W |
Relationship: |
Director |
City: |
Sunnyvale |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
10 |
|
Direct
Shares |
252,099 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$2,561,599 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
252,099 |
|
|
Total
Value |
$2,561,599 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Nuvelo Inc |
ABIO |
Director |
2008-05-30 |
3,580 |
2004-02-27 |
0 |
Premium* |
|
Onyx Pharmaceuticals Inc |
ONXX |
EVP, R&D and Tech. Ope... |
2012-07-25 |
77,756 |
2010-02-01 |
0 |
Premium* |
|
Santarus Inc |
SNTS |
Director |
2014-01-02 |
0 |
2012-03-09 |
0 |
Premium* |
|
Amicus Therapeutics Inc |
FOLD |
Director |
2020-06-04 |
131,000 |
2014-03-12 |
0 |
Premium* |
|
Global Blood Therapeutics, Inc. |
GBT |
President and CEO, Dir... |
2022-10-05 |
0 |
2022-10-05 |
0 |
Premium* |
|
Cascadian Therapeutics, Inc |
CASC |
Director |
2018-03-09 |
0 |
2015-09-05 |
0 |
Premium* |
|
Portola Pharmaceuticals Inc |
PTLA |
Director |
2020-07-02 |
0 |
2019-09-18 |
0 |
Premium* |
|
Royalty Pharma Plc |
RPRX |
Director |
2023-06-23 |
36,941 |
|
0 |
Premium* |
|
Seagen Inc |
SGEN |
|
2023-12-14 |
0 |
2020-08-17 |
0 |
Premium* |
|
Gilead Sciences Inc |
GILD |
Director |
2024-05-08 |
2,822 |
2024-02-02 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
123 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 2 of 5
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
GBT |
Global Blood Therapeutics... |
CEO and President |
|
2016-07-01 |
4 |
D |
$3.40 |
$84,391 |
D/D |
(24,821) |
1,139,815 |
0 |
- |
|
GBT |
Global Blood Therapeutics... |
President and CEO |
|
2016-07-01 |
4/A |
D |
$3.40 |
$84,391 |
D/D |
(24,821) |
1,117,815 |
0 |
- |
|
GBT |
Global Blood Therapeutics... |
CEO and President |
|
2016-07-31 |
5 |
A |
$15.20 |
$5,746 |
D/D |
378 |
1,143,014 |
0 |
- |
|
GBT |
Global Blood Therapeutics... |
CEO and President |
|
2017-01-31 |
5 |
A |
$13.73 |
$19,400 |
D/D |
1,413 |
1,144,427 |
0 |
- |
|
GBT |
Global Blood Therapeutics... |
See Remarks |
|
2017-08-01 |
4 |
D |
$25.10 |
$113,778 |
D/D |
(4,533) |
1,151,956 |
0 |
- |
|
GBT |
Global Blood Therapeutics... |
See Remarks |
|
2017-08-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
12,062 |
1,156,489 |
0 |
- |
|
GBT |
Global Blood Therapeutics... |
See Remarks |
|
2017-08-11 |
4 |
D |
$3.40 |
$421,340 |
D/D |
(124,106) |
1,027,850 |
0 |
- |
|
GBT |
Global Blood Therapeutics... |
See Remarks |
|
2018-01-16 |
4 |
D |
$52.10 |
$890,024 |
D/D |
(17,083) |
1,045,767 |
0 |
- |
|
GBT |
Global Blood Therapeutics... |
See Remarks |
|
2018-01-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
35,000 |
1,062,850 |
0 |
- |
|
GBT |
Global Blood Therapeutics... |
See Remarks |
|
2018-01-24 |
4 |
D |
$58.15 |
$1,009,135 |
D/D |
(17,354) |
1,063,413 |
0 |
- |
|
GBT |
Global Blood Therapeutics... |
See Remarks |
|
2018-01-24 |
4 |
OE |
$0.00 |
$0 |
D/D |
35,000 |
1,080,767 |
0 |
- |
|
GBT |
Global Blood Therapeutics... |
See Remarks |
|
2018-01-31 |
4 |
OE |
$0.00 |
$0 |
D/D |
35,000 |
1,098,413 |
0 |
- |
|
GBT |
Global Blood Therapeutics... |
See Remarks |
|
2018-01-31 |
4 |
D |
$57.90 |
$1,004,739 |
D/D |
(17,353) |
1,081,060 |
0 |
- |
|
GBT |
Global Blood Therapeutics... |
See Remarks |
|
2018-02-01 |
4 |
D |
$59.60 |
$356,468 |
D/D |
(5,981) |
1,087,142 |
0 |
- |
|
GBT |
Global Blood Therapeutics... |
See Remarks |
|
2018-02-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
12,063 |
1,093,123 |
0 |
- |
|
GBT |
Global Blood Therapeutics... |
See Remarks |
|
2018-02-14 |
4 |
D |
$62.30 |
$1,081,092 |
D/D |
(17,353) |
1,105,785 |
0 |
- |
|
GBT |
Global Blood Therapeutics... |
See Remarks |
|
2018-02-14 |
4 |
OE |
$0.00 |
$0 |
D/D |
35,000 |
1,123,138 |
0 |
- |
|
GBT |
Global Blood Therapeutics... |
See Remarks |
|
2018-07-16 |
4 |
OE |
$16.40 |
$199,982 |
D/D |
12,194 |
1,117,979 |
0 |
- |
|
GBT |
Global Blood Therapeutics... |
See Remarks |
|
2018-08-01 |
4 |
D |
$43.15 |
$466,710 |
D/D |
(10,816) |
1,128,975 |
0 |
- |
|
GBT |
Global Blood Therapeutics... |
See Remarks |
|
2018-08-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
21,812 |
1,139,791 |
0 |
- |
|
GBT |
Global Blood Therapeutics... |
See Remarks |
|
2019-01-31 |
4 |
A |
$36.68 |
$21,238 |
D/D |
579 |
1,143,553 |
0 |
- |
|
GBT |
Global Blood Therapeutics... |
See Remarks |
|
2019-02-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
21,813 |
1,150,788 |
0 |
- |
|
GBT |
Global Blood Therapeutics... |
See Remarks |
|
2019-02-01 |
4 |
D |
$48.44 |
$378,510 |
D/D |
(7,814) |
1,142,974 |
0 |
- |
|
GBT |
Global Blood Therapeutics... |
See Remarks |
|
2019-04-08 |
4 |
D |
$58.51 |
$1,015,383 |
D/D |
(17,354) |
1,161,199 |
0 |
- |
|
GBT |
Global Blood Therapeutics... |
See Remarks |
|
2019-04-08 |
4 |
OE |
$0.00 |
$0 |
D/D |
35,000 |
1,178,553 |
0 |
- |
|
123 Records found
|
|
Page 2 of 5 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|